Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Fact Sheet  (TCPH)



For You: Midcap Stocks Research at Less than Its Launch Price


Here is the latest financial fact sheet of MARKSANS PHARMA.. For more details, see the MARKSANS PHARMA. quarterly results and MARKSANS PHARMA. share price. For a sector overview, read our pharmaceuticals sector report.

MARKSANS PHARMA. Price History

Price Rs 176.5
Mkt Cap Rs m 79,983
Vol '000 1,143.3
P/E X 25.0
P/CF X 25.2
EPS (TTM) Rs 7.1
1 Day % 13.2
No. of shares m 453.16
1 Week % 9.1
1 Month % 21.6
1 Year % 126.7
52 week H/L Rs 179.1/70.2
As on Apr 16, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MARKSANS PHARMA. Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
MARKSANS PHARMA. EQUITY SHARE DATA
High Rs4127669874 
Low Rs2210134339 
Sales per share (Unadj.) Rs24.427.733.636.440.9 
Earnings per share (Unadj.) Rs2.03.05.84.65.9 
Diluted earnings per shareRs1.82.75.34.15.9 
Cash flow per share (Unadj.) Rs2.53.66.75.77.0 
Dividends per share (Unadj.) Rs0.050.100.250.250.50 
Adj. dividends per shareRs0.050.090.230.230.50 
Avg Dividend yield %0.20.50.60.40.9 
Book value per share (Unadj.) Rs13.315.521.727.138.5 
Adj. book value per shareRs12.014.019.624.538.5 
Shares outstanding (eoy) m409.31409.31409.31409.31453.16 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.30.71.21.91.4 
Avg P/E ratio x15.96.26.815.49.7 
P/CF ratio (eoy) x12.45.15.912.58.1 
Price / Book Value ratio x2.41.21.82.61.5 
Dividend payout %2.53.44.35.58.5 
Avg Mkt Cap Rs m12,8017,52116,18828,83625,631 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,5911,6841,9732,2032,394 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
MARKSANS PHARMA. INCOME DATA
Net Sales Rs m10,00111,34213,76214,90818,521 
Other income Rs m46367419593 
Total revenues Rs m10,04711,34513,82915,32719,115 
Gross profit Rs m1,3211,9233,3962,5893,393 
Depreciation Rs m228267362448519 
Interest Rs m9787808491 
Profit before tax Rs m1,0431,5723,0222,4753,377 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m239364636607723 
Profit after tax Rs m8041,2082,3851,8682,653 
Gross profit margin %13.217.024.717.418.3 
Effective tax rate %22.923.221.124.521.4 
Net profit margin %8.010.617.312.514.3 
MARKSANS PHARMA. BALANCE SHEET DATA
Current assets Rs m5,3145,9369,02812,25116,997 
Current liabilities Rs m2,3262,2882,9903,8013,654 
Net working cap to sales %29.932.243.956.772.0 
Current ratio x2.32.63.03.24.7 
Inventory Days Days02116 
Debtors Days Days64,453,43578,313,067729782 
Net fixed assets Rs m2,7103,0843,2524,3505,246 
Share capital Rs m409409409409453 
"Free" reserves Rs m5,0165,9518,45610,68216,998 
Net worth Rs m5,4256,3608,86511,09217,452 
Long term debt Rs m00000 
Total assets Rs m8,0259,02012,28016,60122,242 
Interest coverage x11.819.038.830.338.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.21.31.10.90.8 
Return on assets %11.214.420.111.812.3 
Return on equity %14.819.026.916.815.2 
Return on capital %21.026.135.023.119.9 
Exports to sales %00000 
Imports to sales %3.35.27.47.07.3 
Exports (fob) Rs m00000 
Imports (cif) Rs m3315861,0141,0401,348 
Fx inflow Rs m4,0874,2665,8746,4196,491 
Fx outflow Rs m4717371,0141,0401,348 
Net fx Rs m3,6163,5294,8605,3795,143 
MARKSANS PHARMA. CASH FLOW
From Operations Rs m 274 2,333 1,786 993 2,374 
From Investments Rs m -135 -596 -448 -844 -2,592 
From Financial Activity Rs m -208 -1,136 -153 795 1,978 
Net Cashflow Rs m -69 602 1,185 944 1,760 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 43.9%
Institution 20.7%
Non-Institution 35.4%
Total 100.0%
Free Float 56.1%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 11th Floor " Grandeur " Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara Andheri (W), Mumbai - 400053
E-mail companysecretary@marksanspharma.com Web www.marksanspharma.com
Tel 022- 40012000 Fax 022- 40012011 / 40012099
Sector PHARMACEUTICALS Group Private sector
Tr Agent Bigshare Services Pvt Ltd, Office No S6-2 6th Floor Pinnacle Business Park, Next to Ahura Centre Mahakali Caves Road, Andheri (E)
CHM: Mark Saldanha COMP SEC: Harshavardhan Panigrahi YEAR OF INC: 1992 BSE CODE: 524404 FV (Rs): 1 DIV YIELD (%): 0.3

Read: MARKSANS PHARMA. 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    



 

Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.